KMDA FY 2020 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$495M

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$133M+4.8% YoY

Gross Profit

$48M35.7% margin

Operating Income

$19M14.4% margin

Net Income

$17M12.9% margin

EPS (Diluted)

$0.41

Cash Flow

Operating Cash Flow

$19M

Free Cash Flow

$14M

Stock-Based Comp.

$977,000

Balance Sheet

Total Assets

$211M

Total Liabilities

$32M

Stockholders' Equity

$179M

Cash & Equivalents

$70M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$133M	$127M	+4.8%
Gross Profit	$48M	$50M	-4.4%
Operating Income	$19M	$23M	-15.6%
Net Income	$17M	$22M	-23.0%